UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: Triolif-Mint-Lozenge-SE-AJ-APD - XML Representation

Raw xml | Download



<AdministrableProductDefinition xmlns="http://hl7.org/fhir">
  <id value="Triolif-Mint-Lozenge-SE-AJ-APD"/>
  <meta>
    <profile
             value="http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition Triolif-Mint-Lozenge-SE-AJ-APD</b></p><a name="Triolif-Mint-Lozenge-SE-AJ-APD"> </a><a name="hcTriolif-Mint-Lozenge-SE-AJ-APD"> </a><a name="hcTriolif-Mint-Lozenge-SE-AJ-APD-en-US"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-Triolif-Mint-Lozenge-SE-AJ-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-xxxxxxxxx-00049612,http://ema.europa.eu/fhir/eurdId#206; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Lozenge; indication = Symptomlindring vid halsont hos vuxna och ungdomar över 12 år; legalStatusOfSupply = Medicinal product not subject to medical prescription; classification = various</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073703}">Lozenge</span></p><p><b>producedFrom</b>: <a href="ManufacturedItemDefinition-Triolif-Mint-Lozenge-SE-AJ-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Lozenge; unitOfPresentation = Lozenge</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073621}">Oropharyngeal use</span></p></blockquote><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073620}">Oromucosal use</span></p></blockquote></div>
  </text>
  <status value="active"/>
  <formOf>🔗 
    <reference
               value="MedicinalProductDefinition/Triolif-Mint-Lozenge-SE-AJ-MPD"/>
  </formOf>
  <administrableDoseForm>
    <coding>
      <system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
      <code value="100000073703"/>
      <display value="Lozenge"/>
    </coding>
  </administrableDoseForm>
  <producedFrom>🔗 
    <reference
               value="ManufacturedItemDefinition/Triolif-Mint-Lozenge-SE-AJ-MID"/>
  </producedFrom>
  <routeOfAdministration>
    <code>
      <coding>
        <system value="https://spor.ema.europa.eu/v1/lists/100000073345"/>
        <code value="100000073621"/>
        <display value="Oropharyngeal use"/>
      </coding>
    </code>
  </routeOfAdministration>
  <routeOfAdministration>
    <code>
      <coding>
        <system value="https://spor.ema.europa.eu/v1/lists/100000073345"/>
        <code value="100000073620"/>
        <display value="Oromucosal use"/>
      </coding>
    </code>
  </routeOfAdministration>
</AdministrableProductDefinition>